S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

COMPASS Pathways Plc American Depository Shares

CMPS XNAS
$11.73 -0.28 (-2.31%) ▼ 15-min delayed
Open
$12.39
High
$12.39
Low
$11.54
Volume
3.09M
Market Cap
$1.63B

About COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 156 Website →

Key Financials

Period Revenue Net Income EPS
Q1 2026 $0 $91.20M $0.71
FY 2025 $0 $-287,862,000 $-3.08
Q3 2025 $0 $-137,717,000 $-1.44
Q2 2025 $0 $-38,403,000 $-0.41

Get CMPS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on COMPASS Pathways Plc American Depository Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.